ACN vs. EDIT

Last updated Jun 13, 2026

ACN (Accenture plc) and EDIT (Editas Medicine, Inc.) are both stocks. ACN operates in Information Technology Services (Technology), while EDIT operates in Biotechnology (Healthcare). Over the past 10 years, ACN returned 5.50%/yr vs -22.22%/yr for EDIT. At a 0.28 correlation, their price movements are largely independent.

Performance

ACN vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Accenture plc (ACN) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ACN achieves a -35.62% return, which is significantly lower than EDIT's 21.95% return. Over the past 10 years, ACN has outperformed EDIT with an annualized return of 5.50%, while EDIT has yielded a comparatively lower -22.22% annualized return.

ACN

• 1D: 1.65%
• 1M: 0.86%
• YTD: -35.62%
• 6M: -36.39%
• 1Y: -43.95%
• 3Y*: -16.94%
• 5Y*: -8.24%
• 10Y*: 5.50%

EDIT

• 1D: 2.46%
• 1M: -4.58%
• YTD: 21.95%
• 6M: -1.19%
• 1Y: 26.90%
• 3Y*: -39.82%
• 5Y*: -41.79%
• 10Y*: -22.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ACN vs. EDIT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ACN Accenture plc	-35.62%	-22.14%	1.86%	33.60%	-34.75%	60.67%	26.04%	51.21%	-6.23%	33.34%
EDIT Editas Medicine, Inc.	21.95%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-25.97%	89.34%

Correlation

The correlation between ACN and EDIT is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (10Y) Calculated over the trailing 10-year period	0.28
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016	0.28

The correlation between ACN and EDIT shifts across timeframes, from 0.09 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ACN : $106.02B EDIT : $244.70M
EPS ACN : $12.27 EDIT : -$1.21
PS Ratio ACN : 1.48 EDIT : 6.29
PB Ratio ACN : 3.40 EDIT : 55.51
Total Revenue (TTM) ACN : $72.11B EDIT : $35.86M
Gross Profit (TTM) ACN : $23.06B EDIT : $35.86M
EBITDA (TTM) ACN : $12.11B EDIT : -$76.66M

Return for Risk

ACN vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACN

ACN Risk / Return Rank: 3
ACN Sharpe Ratio Rank: 2
ACN Sortino Ratio Rank: 3
ACN Omega Ratio Rank: 4
ACN Calmar Ratio Rank: 5
ACN Martin Ratio Rank: 3

EDIT

EDIT Risk / Return Rank: 51
EDIT Sharpe Ratio Rank: 48
EDIT Sortino Ratio Rank: 56
EDIT Omega Ratio Rank: 53
EDIT Calmar Ratio Rank: 49
EDIT Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACN vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Accenture plc (ACN) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ACN	EDIT	Difference
Sharpe ratio: Return per unit of total volatility	-1.26	0.16	-1.41
Sortino ratio: Return per unit of downside risk	-1.93	0.98	-2.92
Omega ratio: Gain probability vs. loss probability	0.77	1.11	-0.34
Calmar ratio: Return relative to maximum drawdown	-0.94	0.25	-1.19
Martin ratio: Return relative to average drawdown	-1.72	0.43	-2.16

ACN vs. EDIT - Sharpe Ratio Comparison

The current ACN Sharpe Ratio is -1.26, which is lower than the EDIT Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of ACN and EDIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ACN vs. EDIT - Drawdown Comparison

The maximum ACN drawdown since its inception was -59.20%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for ACN and EDIT.

Drawdown Indicators

	ACN	EDIT	Difference
Max Drawdown Largest peak-to-trough decline	-59.20%	-98.92%	+39.72%
Max Drawdown (1Y) Largest decline over 1 year	-47.89%	-59.88%	+11.99%
Max Drawdown (3Y) Largest decline over 3 years	-58.67%	-91.18%	+32.51%
Max Drawdown (5Y) Largest decline over 5 years	-58.67%	-98.66%	+39.99%
Max Drawdown (10Y) Largest decline over 10 years	-58.67%	-98.92%	+40.25%
Current Drawdown Current decline from peak	-55.91%	-97.24%	+41.33%
Average Drawdown Average peak-to-trough decline	-12.89%	-62.63%	+49.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.93%	34.03%	-7.10%

Volatility

ACN vs. EDIT - Volatility Comparison

The current volatility for Accenture plc (ACN) is 12.95%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that ACN experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ACN	EDIT	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.95%	32.34%	-19.39%
Volatility (6M) Calculated over the trailing 6-month period	29.81%	61.63%	-31.82%
Volatility (1Y) Calculated over the trailing 1-year period	36.02%	94.75%	-58.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.60%	94.12%	-65.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.87%	83.80%	-56.93%

Dividends

ACN vs. EDIT - Dividend Comparison

ACN's dividend yield for the trailing twelve months is around 3.74%, while EDIT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ACN Accenture plc	3.74%	2.26%	1.52%	1.33%	1.51%	0.87%	1.26%	1.07%	1.98%	1.66%	1.97%	2.03%
EDIT Editas Medicine, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both ACN and EDIT in my portfolio?

ACN and EDIT have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ACN or EDIT?

EDIT has higher volatility (32.34%) compared to ACN (12.95%). In terms of maximum drawdown, ACN dropped -59.20% vs EDIT's -98.92%.

Which has better risk-adjusted returns?

EDIT currently has the higher Sharpe Ratio (0.16 vs -1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.